8-K: Abacus Life Reports Strong Q3 2024 Results with 33% Revenue Growth

Abacus Life announced a 33% year-over-year increase in total revenue for the third quarter of 2024, alongside significant growth in adjusted net income and EBITDA.

Summary

• Abacus Life reported its financial results for the third quarter of 2024, showing a 33% increase in total revenue to $28.1 million compared to $21.1 million in the same period last year.
• The company experienced a GAAP net loss of $5.1 million, primarily due to a non-cash increase in warrant liability of $7.8 million, increased stock compensation expenses of $1.8 million, and increased interest expense of $1.5 million.
• However, adjusted net income grew by 65% year-over-year to $14.9 million, and adjusted EBITDA increased by 54% to $16.7 million.
• Origination capital deployment rose to $93.2 million, up from $56.4 million, and policy originations increased by 54% to 278.
• The company's annualized return on invested capital (ROIC) was 21%, and the annualized return on equity (ROE) was 23%.
• Abacus Life had $19.4 million in cash and cash equivalents, $274.4 million in balance sheet policy assets, and $166.5 million in outstanding long-term debt as of September 30, 2024.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong revenue and profitability growth, although there are some concerns about the GAAP net loss. The company's strategic initiatives and future outlook are also encouraging.

Positives

• Abacus Life demonstrated strong revenue growth, with a 33% increase year-over-year.
• The company's adjusted net income and EBITDA showed substantial growth, indicating improved profitability.
• There was a significant increase in capital deployment and policy originations, suggesting strong business activity.
• The adjusted EBITDA margin improved, reflecting better operational efficiency.
• The company's ROIC and ROE are both strong, indicating effective use of capital and equity.

Negatives

• The company reported a GAAP net loss of $5.1 million, primarily due to non-cash items and increased expenses.
• The non-cash increase in warrant liability significantly impacted the GAAP net loss.
• Increased employee stock compensation and interest expenses also contributed to the net loss.

Risks

• The company's loss reserves are based on estimates and may be inadequate to cover actual losses.
• There is a risk of failure to properly price insurance policies.
• The company's business is geographically concentrated, which could pose a risk.
• The industry is cyclical, which could impact future performance.
• Regulatory changes could negatively affect the business.
• Competition could impact the company's market share and profitability.
• The company's relationships with independent agencies could be disrupted.
• There is a risk of not meeting investment objectives.
• The company may be unable to raise capital on favorable terms or at all.
• Acts of terrorism could impact the business.
• There is a risk of control deficiencies.

Future Outlook

The company expects to close the acquisitions of Carlisle Management and FCF Advisors by the end of the fourth quarter, subject to regulatory approval, and remains well-positioned to deliver sustained growth and profitability.

Management Comments

• Jay Jackson, Chief Executive Officer of Abacus, stated that it was another great quarter for Abacus as they continued to deliver meaningful growth and profitability, while successfully executing on their long-term strategy.
• He also highlighted the significant advancements made with the ABL Tech platform and the progress in the announced acquisitions.

Industry Context

Abacus Life operates in the alternative asset management sector, specializing in life settlements. The company's focus on longevity data and actuarial technology positions it uniquely within this space, offering uncorrelated investment opportunities. The growth in revenue and profitability aligns with the broader trend of increasing investor interest in alternative assets.

Comparison to Industry Standards

• Abacus Life's 33% revenue growth is strong compared to some traditional asset managers, but it is important to compare it to other alternative asset managers focused on life settlements.
• Companies like GWG Holdings (prior to its bankruptcy) and other private life settlement funds would be relevant comparables, though direct comparisons are difficult due to varying reporting standards and business models.
• The 54% growth in adjusted EBITDA is a positive sign, indicating strong operational performance, and should be compared to the growth rates of similar alternative asset managers.
• The ROIC of 21% and ROE of 23% are solid, but should be benchmarked against the returns of other alternative investment strategies and funds.
• The company's focus on technology, particularly the ABL Tech platform, is a differentiator and should be compared to the technological capabilities of other firms in the space.

Stakeholder Impact

• Shareholders will benefit from the company's strong financial performance and growth prospects.
• Employees may benefit from the company's success and growth.
• Customers will benefit from the company's innovative products and services.
• Suppliers and creditors will benefit from the company's financial stability.

Next Steps

• The company plans to close the acquisitions of Carlisle Management and FCF Advisors by the end of the fourth quarter.
• Abacus will continue to develop and expand its ABL Tech platform.
• The company will continue to focus on delivering sustained growth and profitability.

Key Dates

Keywords

life settlements, alternative asset management, longevity data, actuarial technology, financial results, revenue growth, EBITDA, net income, ROIC, ROE, policy originations, capital deployment